[Federal Register Volume 66, Number 101 (Thursday, May 24, 2001)]
[Notices]
[Page 28757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13109]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: June 14-15, 2001.
    Date: June 15-14, 2001.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: The committee will review selected human gene transfer 
protocols; NIH policy on serious adverse event reporting; data 
management activities related to human gene transfer clinical 
trials; discussion on the risk group designation for E. coli strain 
B; and other matters to be considered by the Committee.
    Place: Natcher Building, Conference Room D, 45 Center Drive, 
Bethesda, MD 20892.
    Contact Person: Amy P. Patterson, MD, Acting Executive 
Secretary, Office of Biotechnology Activities, National Institutes 
of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 301-
496-9838.
    Information is also available on the Institute's/Center's home 
page: www4.od.nih.gov/oba/, where an agenda and any additional 
information for the meeting will be posted when available.

    Note: ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually ever NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.


    Dated: May 17, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-13109 Filed 5-23-01; 8:45 am]
BILLING CODE 4140-01-M